Niagen Bioscience, Inc.
NAGE
$4.78
-$0.04-0.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.43% | 9.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.43% | 9.22% | |||
| Cost of Revenue | 0.64% | 10.72% | |||
| Gross Profit | -1.02% | 8.41% | |||
| SG&A Expenses | 12.54% | 2.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.68% | 6.51% | |||
| Operating Income | -50.35% | 33.00% | |||
| Income Before Tax | -7.83% | 28.45% | |||
| Income Tax Expenses | 31.53% | 73.44% | |||
| Earnings from Continuing Operations | -9.74% | 26.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.74% | 26.85% | |||
| EBIT | -50.35% | 33.00% | |||
| EBITDA | -48.05% | 31.06% | |||
| EPS Basic | -9.93% | 26.15% | |||
| Normalized Basic EPS | -49.20% | 27.46% | |||
| EPS Diluted | 0.00% | 25.00% | |||
| Normalized Diluted EPS | -48.27% | 27.68% | |||
| Average Basic Shares Outstanding | 0.09% | 0.67% | |||
| Average Diluted Shares Outstanding | -1.54% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||